COMMUNIQUÉS West-GlobeNewswire

SK pharmteco and GEMMABio Expand Rare Disease Manufacturing Collaboration Following Important Spinal Muscular Atrophy (SMA) Clinical Trial Milestone
22/09/2026
First patient dosed marks an important step for the SMA community and highlights a growing rare disease manufacturing partnership, with future GEMMABio programs expected to leverage SK pharmteco’s SKyvec™ viral vector [...]
TETmedical Strengthens Board of Directors with Appointment of Marc Lebel and Patrick McBrayer, Veteran Life Sciences Entrepreneurs and Company Builders
22/09/2026
New Directors Bring Track Record of Founding, Scaling, and Exiting Institutionally-Backed MedTech and Life Sciences Companies as TETmedical Advances Its Pivotal Study FAIR HAVEN, N.J and ITHACA, N.Y., Sept. 22, 2026 ( [...]
SafeSpace Global Secures Up to $11 Million in Financing Capacity to Support Next Phase of Growth
22/09/2026
Multi-year financing framework expands access to growth capital and provides increased financial flexibility as SafeSpace Global KNOXVILLE, Tenn., Sept. 22, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID: [...]
X-Chem Announces Phase 3 Milestone in Collaboration with Relay Therapeutics
22/09/2026
WALTHAM, Mass., Sept. 22, 2026 (GLOBE NEWSWIRE) -- X-Chem, a global leader in innovative drug discovery services, announced the achievement of a milestone following Relay Therapeutics’ initiation of a Phase 3 clinical [...]
Porch Light Health and CBHC Expand Access to Methadone Treatment in Northern Colorado
22/09/2026
New medication units in Fort Collins and Greeley bring methadone treatment into existing Porch Light Health outpatient addiction clinics DENVER, Sept. 22, 2026 (GLOBE NEWSWIRE) -- As drug overdose deaths continue to [...]
Eclipse Energy and Wood Validate Pathway to Low-Cost, Ultra-Low-Carbon Hydrogen from Depleted Oil Reservoirs
22/09/2026
RenovaStrata™ H2 achieves modeled LCOH as low as $0.56/kg and carbon intensity of 0.076 kgCO₂e/kgH₂, reinforcing potential for commercial-scale, ultra-low-carbon hydrogen HOUSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) -- [...]
New Study Reveals When College Students at Risk for Suicide Begin to Improve in Virtual Therapy
22/09/2026
Peer-reviewed TimelyCare research published in DIGITAL HEALTH finds many students show early improvement while underscoring the need for continued suicide risk monitoring. Fort Worth, TX, Sept. 22, 2026 (GLOBE NEWSWIRE [...]
Ophirex Publishes Data from Phase 2 BRAVIO Trial Evaluating Intravenous Followed by Oral Varespladib for Snakebite
22/09/2026
Trial evaluated varespladib administered after antivenom across multiple snake species in India and the United States Clinically important signals of benefit observed in patients bitten by kraits and copperheads CORTE [...]
Seek Labs Launches Open Impact Program at Clinton Global Initiative to Advance Therapeutic Development for Neglected Infectious Diseases
22/09/2026
New Commitment to Action will apply Seek Labs’ BioSeeker AI and Sequence Ablation Therapeutics platform to diseases historically underserved by traditional therapeutic development SALT LAKE CITY, Sept. 22, 2026 (GLOBE [...]
Rendever Expands Dementia & Empathy Training With a New Mode for Family Caregivers
22/09/2026
New feature brings guidance from a family caregiver turned dementia researcher directly into the immersive training, helping families navigate a loved one's condition at home BOSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) -- [...]
Kylo Peptides Strengthens U.S.-Based Supply Chain for Research Peptides with Faster Domestic Fulfillment
22/09/2026
Sheridan, Wyoming, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides [ https://kylopeptides.com/ ] has strengthened domestic fulfillment for research peptides, routing more order flow through one U.S. warehouse so [...]
Zealand Pharma announces initiation of the registrational Phase 3 ZUPREME program of petrelintide in people with overweight or obesity
22/09/2026
Press release – No. 17 / 2026 Zealand Pharma announces initiation of the registrational Phase 3 ZUPREME program of petrelintide in people with overweight or obesity The Phase 3 initiation marks a defining step toward [...]
SK pharmteco et GEMMABio renforcent leur collaboration dans la fabrication de traitements pour les maladies rares après une étape clé de l’essai clinique consacré à l’amyotrophie spinale (SMA)
22/09/2026
L’administration du traitement au premier patient constitue une étape importante pour la communauté des personnes atteintes de SMA et témoigne du renforcement de la collaboration dans le domaine de la fabrication de [...]
Applied Biologics Announces Last Patient, Last Visit in CAMPX Randomized Controlled Trial of XWRAP®
22/09/2026
Completion of patient follow-up marks major clinical milestone as 222-patient diabetic foot ulcer study advances toward database lock and final analysis SCOTTSDALE, Ariz., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Applied [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 38 - 2026
22/09/2026
Aggregated presentation by day and by market Weekly report on share repurchases from 14th September to 18th September 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial [...]
Zenas BioPharma Announces Upcoming Presentations of Obexelimab Data in IgG4-Related Disease at the IgG4ward! 6th International Symposium on IgG4-Related Disease and ACR Convergence 2026
22/09/2026
– New data from the Phase 3 INDIGO open-label extension will include the longer-term flare protection and safety data of obexelimab in IgG4-RD – – Additional analyses will assess glucocorticoid-associated toxicity and [...]
OrthoPediatrics Surpasses 1,000 PNP Tibia Nail Implantations
22/09/2026
WARSAW, Ind., Sept. 22, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]
CorVel Expands Managed Care Connectivity with the CareMC® Extension for Guidewire ClaimCenter
22/09/2026
FORT WORTH, Texas, Sept. 22, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL), a national provider of risk management and healthcare solutions, today announced the availability of its Care MC Accelerator for [...]
CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference
22/09/2026
BOSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today announced that [...]

Pages